Text Box: 601 Pennsylvania Avenue, N.W.
Suite 900, South Building 
Washington, D.C.  20004-2601
Tel: 202-220-3172
Fax: 202-639-8238
Board of Directors:
A. J. (Jim) Norby
Bill Kadereit
Vice President,
Legislative Affairs
John Leasher
Vice President,
JoAnn Alix-Gagain
Jane Banfield
Joseph R. (Dick) Ciocca
Robert Foresta
Chuck Gilbert
Michael Calabrese
Phyllis Borzi
Legislative Counsel:
Marta Bascom
Media Relations Director:
 Ed Beltram
Member Organizations:
Aetna Retirees Association
Ameritech/SBC Retirees
AT&T Retirees (ACER)
      Boeing Engineering Retirees Society
CWA-CUTW Retired Members
Daimler-Chrysler Retirees
Detroit Edison Alliance of  Retirees (DEAR)
GM Retirees-Detroit Diesel
IBM Retirees
Johns Manville Retirees
Lucent Retirees Organization
Monsanto/Solutia Retirees
NAPRI (Prudential)
Northwestern Bell/Association of US WEST Retirees
Portland GE-Enron
Southern New England Tell  
Retirees Association, Inc. (SRA)
TelCo Retirees Association


 April 11, 2007


The Honorable Max Baucus

Chairman, Committee on Finance

United States Senate 

511 Hart Senate Office Bldg.

Washington, DC 20510


Dear Senator Baucus: 


It is of extreme importance to all retirees that the "Medicare Prescription Drug Price Negotiation Act of 2007" be voted out of the Senate Committee on Finance and brought to the Senate floor for a vote.  While Medicare Part D has provided savings for tens of millions of retirees, the price of many prescription drugs are still far too costly and are continuing to increase at an alarming rate.  Therefore, legislation is needed that will make negotiations for lower prices mandatory, and not simply discretionary. 


There are several instances when this is particularly imperative, such as when there is a single source for a drug that is without a therapeutic equivalent in the marketplace.  To place retirees at the mercy of the pharmaceutical companies when there is only one drug on the market, without requiring negotiations for the pricing of that drug, creates an all too familiar burden on the shoulders of those who can least afford it.  In situations such as these, negotiations are the only protection retirees have against skyrocketing prescription drug costs, and they should, and must, be made mandatory. This is particularly true in cases where retirees are stuck in the "doughnut hole," having to buy expensive branded drugs at a time when insurance companies such as Humana and Sierra are either abandoning coverage or raising premiums inordinately to offset the high cost of these drugs.


It is also widely reported that some members of the Senate are threatening to filibuster the bill to prevent it from coming up for a vote.  Retirees deserve to have this bill brought to the floor for a vote.  America’s seniors should not have to wait any longer for the Senate to pass legislation that will mandate price negotiations for prescription drugs for Medicare participants.


Sincerely yours,

President, National Retiree Legislative Network


Copy to:

U.S. Senate Committee on Finance Members



return to NRLN HOME PAGE